Published in Cancer Weekly, August 9th, 1999
S. Kalyanasundaram and colleagues from Birmingham, Alabama, investigated a novel gene delivery method ("Coacervate Microspheres as Carriers of Recombinant Adenoviruses," Cancer Gene Therapy, 1999;6(2):107-112).
"The therapeutic utility of recombinant adenoviruses (rAds) is limited in part by difficulties in directing the viruses to specific sites and by the requirement for bolus administration, both of which limit the efficiency of target tissue infection," wrote Kalyanasundaram et al. "As a first step toward overcoming these limitations, rAds were...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.